Brainstorm Cell Therapeutics (BCLI) News Today → [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (From DeFi Distribution) (Ad) Free BCLI Stock Alerts $0.43 +0.02 (+5.08%) (As of 02:13 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 7 at 3:34 AM | americanbankingnews.comBrainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Price Passes Above 200-Day Moving Average of $0.40May 20, 2024 | prnewswire.comBrainStorm Cell Therapeutics to Present New Biomarker Data Suggesting ALS Patients May Benefit From Longer-Term Treatment with NurOwnMay 16, 2024 | msn.comBrainStorm Cell Therapeutics GAAP EPS of -$0.05 beats by $0.02May 15, 2024 | finanznachrichten.deBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | prnewswire.comBrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate UpdateApril 17, 2024 | finanznachrichten.deBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwnApril 17, 2024 | msn.comBrainStorm Cell Therapeutics promotes Bob Dagher to Chief Medical OfficerApril 17, 2024 | msn.comBrainstorm Cell Therapeutics (BCLI) Price Target Increased by 150.00% to 2.55April 17, 2024 | marketwatch.comBrainStorm Cell Therapeutics Loses Co-CEO Lindborg, Names Dagher as New Medical ChiefApril 11, 2024 | finanznachrichten.deBrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value RuleApril 11, 2024 | finance.yahoo.comBCLI: Receives SPA Agreement from FDA on Design of Phase 3b Trial of NurOwn™…April 11, 2024 | prnewswire.comBrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value RuleApril 10, 2024 | finance.yahoo.comBrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALSApril 10, 2024 | prnewswire.comBrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALSApril 9, 2024 | finance.yahoo.comBrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALSApril 9, 2024 | prnewswire.comBrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALSApril 8, 2024 | prnewswire.comBrainStorm Cell Therapeutics to Provide Update on NurOwn ProgramApril 1, 2024 | benzinga.comBrainstorm Cell: Q4 Earnings InsightsApril 1, 2024 | prnewswire.comBrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate UpdateMarch 25, 2024 | msn.comWhy Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day SessionMarch 6, 2024 | finance.yahoo.comBCLI: Unveils Plans for Phase 3b Trial of NurOwn® in ALS…February 29, 2024 | investing.comBrainStorm details Phase 3b trial for ALS treatment NurOwnFebruary 27, 2024 | finance.yahoo.comBrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific ConferenceFebruary 27, 2024 | prnewswire.comBrainStorm Cell Therapeutics to Unveil Phase 3b NurOwn® Trial Design at MDA Clinical and Scientific ConferenceFebruary 25, 2024 | finance.yahoo.comBCLI Mar 2024 1.500 callFebruary 23, 2024 | marketwatch.comBrainStorm Cell Therapeutics Shares Rise 7.2% on NurOwn Study Request to FDAFebruary 23, 2024 | msn.comBrainStorm submits SPA request to FDA for Phase 3 study designFebruary 23, 2024 | prnewswire.comBrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn® in ALSFebruary 16, 2024 | wsj.comBrainstorm Cell Therapeutics Inc.February 13, 2024 | uk.investing.comBrainstorm Cell Therapeutics Inc (BCLI)February 13, 2024 | finance.yahoo.comBrainStorm Cell Therapeutics to Present at European Life Sciences CEO ForumFebruary 1, 2024 | finance.yahoo.comBrainstorm Cell Therapeutics Inc. (BCLI)January 14, 2024 | seekingalpha.comBCLI Brainstorm Cell Therapeutics Inc.January 1, 2024 | businesswire.comBCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before ...December 26, 2023 | marketwatch.comBrainstorm Cell Therapeutics Shares Rise 11% on Patent ApprovalsDecember 26, 2023 | msn.comBrainStorm Cell Therapeutics spikes on patent winsDecember 26, 2023 | finance.yahoo.comBrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder TreatmentsDecember 22, 2023 | barrons.comINVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Brainstorm Cell Therapeutics Inc.(BCLI) of a Class Action Lawsuit and an Upcoming DeadlineDecember 20, 2023 | finanznachrichten.deBrainStorm Cell Therapeutics Inc.: BrainStorm Issues 2023 Letter to ShareholdersDecember 20, 2023 | finance.yahoo.comBrainStorm Issues 2023 Letter to ShareholdersDecember 17, 2023 | morningstar.comBCLI Investors Have Opportunity to Lead Brainstorm Cell Therapeutics Inc. Securities Fraud LawsuitDecember 16, 2023 | markets.businessinsider.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLIDecember 8, 2023 | finance.yahoo.comBCLI: FDA Meeting Provides Clear Path for Planned Phase 3b Trial of NurOwnDecember 7, 2023 | msn.comWhy BrainStorm Cell Therapeutics Shares Are FallingDecember 7, 2023 | finance.yahoo.comBrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALSNovember 28, 2023 | morningstar.comBrainstorm Cell Therapeutics Inc BCLINovember 26, 2023 | barrons.comINVESTOR ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLINovember 23, 2023 | barrons.comSHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline -- BCLINovember 21, 2023 | benzinga.comBrainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class ActionNovember 21, 2023 | msn.comBrainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plans Get Brainstorm Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Email Address It's time to ween off Chinese lithium! (Ad)As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely Learn how this American company is leading the lithium-ion revolution BCLI Media Mentions By Week BCLI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BCLI News Sentiment▼0.000.76▲Average Medical News Sentiment BCLI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BCLI Articles This Week▼12▲BCLI Articles Average Week Get Brainstorm Cell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CSBR News Today SGMO News Today DBVT News Today BLUE News Today OMGA News Today ATHA News Today VIGL News Today DTIL News Today ALVR News Today IKNA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BCLI) was last updated on 6/10/2024 by MarketBeat.com Staff From Our Partners[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored